COSTA MESA, Calif., Feb. 23 /PRNewswire/ -- Neozyme International, Inc. (Neozyme), a subsidiary of International Daleco Corporation , has received a NONTOX order from its Australian agent. The customer, a major real estate development company, has several, on-site hydrocarbon remediation compliance orders to resolve before construction can begin. Where time of cleanup is financially important, Neozyme's patented NONTOX bioorganic catalyst has proven to accelerate, at an incredible rate, the biological breakdown of hydrocarbon contamination in both soil and water.
A controlled study for the U.S. Air Force, completed in 1997, by a major U.S. engineering company, Metcalf & Eddy, featured the use of NONTOX at a hydrocarbon remediation site on a U.S. base. Concentrations of soluble petroleum were reduced by 50% during a very convincing two-week trial period.
Neozyme manufactures and sells its patented line of bioorganic catalytic formulations for numerous markets including, but not limited to, municipal wastewater treatment, commercial/industrial, hydrocarbon remediation, industrial metal cleaning and agriculture. All Neozyme products are non-toxic, 100% biodegradable and can be safely used around humans, animals, marine life, vegetation and the environment. No special clothing or handling apparatus is required. For more information, please visit http://www.neozyme.com/.
This News Release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based largely on the Company's expectations of forecasts of future events, can be affected by inaccurate assumptions and are subject to various risks and known and unknown uncertainties, a number of which are beyond the Company's control. Therefore, actual results could differ materially from the forward-looking statements herein.
International Daleco Corporation
CONTACT: Parker Dale, Chairman of International Daleco Corporation,+1-949-515-1301, fax, +1-949-515-1314, email@example.com